CompoSecure, Inc. Files 8-K with Financials

Ticker: GPGI · Form: 8-K · Filed: Nov 3, 2025 · CIK: 1823144

Composecure, Inc. 8-K Filing Summary
FieldDetail
CompanyComposecure, Inc. (GPGI)
Form Type8-K
Filed DateNov 3, 2025
Risk Levellow
Pages6
Reading Time7 min
Key Dollar Amounts$0.0001, $4.976 b, $18.50, $1.96 billion
Sentimentneutral

Sentiment: neutral

Topics: financial-statements, exhibits, disclosure

Related Tickers: CMPO

TL;DR

CMPO filed an 8-K on Nov 3, 2025, mostly financials. Nothing major to see here.

AI Summary

On November 3, 2025, CompoSecure, Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, indicating a routine disclosure of financial information and related documents. No specific material events or transactions were detailed in the provided excerpt.

Why It Matters

This filing provides an update on CompoSecure's financial status and exhibits, which is important for investors to assess the company's performance and stability.

Risk Assessment

Risk Level: low — The filing appears to be a routine disclosure of financial statements and exhibits, with no indication of significant new risks or material events.

Key Players & Entities

  • CompoSecure, Inc. (company) — Registrant
  • Roman DBDR Tech Acquisition Corp. (company) — Former company name
  • November 3, 2025 (date) — Date of earliest event reported

FAQ

What is the primary purpose of this 8-K filing for CompoSecure, Inc.?

The primary purpose of this 8-K filing is to report financial statements and exhibits, as indicated by the 'ITEM INFORMATION: Financial Statements and Exhibits' section.

When was the earliest event reported in this filing?

The earliest event reported in this filing occurred on November 3, 2025, as stated in the 'Date of Report (Date of earliest event reported)' field.

What was CompoSecure, Inc.'s former name?

CompoSecure, Inc.'s former name was Roman DBDR Tech Acquisition Corp., with a date of name change on September 1, 2020.

In which state was CompoSecure, Inc. incorporated?

CompoSecure, Inc. was incorporated in Delaware.

What is the principal executive office address for CompoSecure, Inc.?

The principal executive office address for CompoSecure, Inc. is 309 Pierce Street, Somerset, New Jersey 08873.

Filing Stats: 1,720 words · 7 min read · ~6 pages · Grade level 15 · Accepted 2025-11-03 07:36:05

Key Financial Figures

  • $0.0001 — hich registered Class A Common Stock, $0.0001 par value CMPO New York Stock Excha
  • $4.976 b — ggregate consideration of approximately $4.976 billion, comprised of cash and shares of
  • $18.50 — of Common Stock at a purchase price of $18.50 per share, for an aggregate purchase pr
  • $1.96 billion — gregate purchase price of approximately $1.96 billion. The closing of the private placements

Filing Documents

01 Other Events

Item 7.01 Other Events On November 2, 2025, CompoSecure, Inc. ("CompoSecure" or the "Company") entered into a Share Purchase Agreement with entities affiliated with Platinum Equity pursuant to which CompoSecure will combine with Husky Technologies Limited ("Husky") for aggregate consideration of approximately $4.976 billion, comprised of cash and shares of CompoSecure's Class A common stock, par value $0.0001 per share (the "Common Stock"). In conjunction with the closing of CompoSecure's planned business combination with Husky, Husky will become a wholly owned subsidiary of CompoSecure Holdings, and Resolute Holdings Management, Inc. ("Resolute Holdings") will enter into a management agreement with Husky, on substantially the same terms as the existing management agreement between Resolute Holdings and CompoSecure Holdings, L.L.C. Concurrently with the execution of the Share Purchase Agreement, CompoSecure entered into purchase agreements with certain investors named therein pursuant to which the Company agreed to issue and sell to such investors in a private placement an aggregate of approximately 106 million shares of Common Stock at a purchase price of $18.50 per share, for an aggregate purchase price of approximately $1.96 billion. The closing of the private placements is conditioned upon the substantially concurrent consummation of the business combination with Husky, which is expected to close in the first quarter of 2026, subject to customary closing conditions, including regulatory approval. CompoSecure has made available investor presentations regarding the proposed business combination and the transactions related thereto (collectively, the "Transactions"), which are furnished as Exhibits 99.1 and 99.2 to this Current Report on Form 8-K and which are incorporated by reference herein. The information in this Item 7.01, including Exhibit 99.1 and Exhibit 99.2, is furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exch

Forward Looking Statements

Forward Looking Statements This Current Report on Form 8-K contains forward-looking statements within the meaning of the federal securities laws. Statements that are not historical facts, including forward-looking statements. Forward-looking statements are based on current expectations and assumptions and involve risks and uncertainties that could cause actual results to differ materially. Important factors include, among others: (i) the risk that the Transactions may not be completed in a timely manner or at all; (ii) the failure to obtain required approvals, including regulatory approvals and the Company Stockholder Approval; (iii) the occurrence of any event that could give rise to termination of the Share Purchase Agreement; (iv) the effect of the announcement, pendency or consummation of the Transactions on the parties' business relationships, operations, financial and accounting matters; (v) risks that the expected benefits of the Transactions, including financial projections, estimates and outlook, may not be fully realized or may take longer to realize than expected; (vi) risks related to financing the Transactions; (vii) costs related to the Transactions; (viii) potential litigation and/or regulatory actions relating to the Transactions; (ix) general economic, market, industry and competitive conditions; and (x) other risks and uncertainties described in CompoSecure's filings with the Securities and Exchange Commission (the "SEC"), including its Annual Report on Form 10-K for the year ended December 31, 2024 and subsequent Quarterly Reports on Form 10-Q, which identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date made. CompoSecure undertakes no obl

01 Exhibits

Item 9.01 Exhibits. (d) Exhibits Exhibit No. Description 99.1 Investor Call Presentation of the Company 99.2 Investor Presentation of the Company 104 Cover Page Interactive Data File (embedded with the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. COMPOSECURE, INC. Date: November 3, 2025 By: /s/ Thomas R. Knott Name: Thomas R. Knott Title: Chief Investment Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.